2011年度業績−論文

  1. Miura R, Tanaka A, Takikawa H
    Urinary bile acid sulfate levels in patients with primary biliary cirrhosis．Hepatol Res 41, 358-363, 2011
  2. Aithal GP, Watkinsv PB, Andrade RJ, Larrey D, Molokhia M, Takikawa H, Hunt CM, Wilke RA, Avigan M, Kaplowitz N, Bjornsson E, Daly AK
    Case definition and phenotype standardization indrug-induced liver injury．Clin Pharmacol Ther 89, 806-815, 2011
  3. Fukami M, Tanaka A, Takikawa H
    Effect of penicillin G on the biliary excretion of cholephilic compounds in rats．J Hepatobiliary Pancreat Sci 18, 684-688, 2011
  4. Tanaka A, Invernizzi P, Ohira H, Kikuchi K, Nezu S, Kosoy R, Seldin MF, Gershwin ME, Takikawa H
    Replicated association of 17q12-21 with susceptibility of primary biliary cirrhosis in a Japanese cohort．Tissue Antigens 78, 65-68, 2011
  5. Tanaka A, Harada K, Ebinuma H, Komori A, Yokokawa J, Yoshizawa K, Abe M, Miyake Y, Kikuchi K, Ohira H, Zeniya M, Yamamoto K, Ishibashi H, Onji M, Nakanuma Y, Tsubouchi H, Takikawa H
    Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: a rationale for corticosteroids use based on a nation-wide retrospective study in Japan．Hepatol Res 41, 877-886, 2011
  6. Watanabe S, Enomoto N, Koike K, Izumi N, Takikawa H, Hashimoto E, Moriyasu F, Kumada H, Imawari M, PERFECT Study Group
    Cancer preventive effect of pegylated interferon α-2b plus ribavirin in a real-life clinical setting in Japan: PERFECT interim analysis．Hepatol Res 41, 955-964, 2011
  7. Takahashi Y, Inui A, Fujisawa T, Takikawa H, Fukusato T
    Histopathological characteristics of nonalcoholic fatty liver disease in children: Comparison with adult cases．Hepatol Res 41, 1066-1074, 2011
  8. Mitamura K, Hori N, Iida T, Suzuki M, Shimizu T, Nittono H, Takaori K, Takikawa H, Hofmann AF, Ikegawa S
    Ident ication of S-acyl glutathione conjugates of bile acids in human bile by means of LC/ESI-MS．Steroids 76, 1609-1614, 2011
  9. Origasa H, Goto S, Shimada　K,　Uchiyama　S,　Okada　Y,　Sugano　K,  Hiraishi　H,　Uemura　N,　Ikeda　Y　on　behalf　of　the　MAGIC　Investigators
    Prospective cohort study of gastrointestinal complications and vascular diseases in patients taking aspirin: rationale and disign of the MAGIC study．Cardiovasc Drugs Ther, 25(6)：551-560, 2011
  10. Anjiki H, Kamisawa T, Tabata T, Takuma K, Egawa N, Yamamoto T, Kuyama Y, Urita Y, Tando Y, Nakamura T
    Gastric emptying in patients with autoimmune pancreatitis．Pancreas, 40(8)：1302-1306, 2011
  11. 中沼安二、石橋大海、滝川　一、坪内博仁
    PBCの新しい病期・活動度分類の提案．日消誌, 108：1817-1822, 2011
  12. 滝川　一
    薬物性肝障害−早期発見と早期対応のポイントを含めて．日本医事新報, 4537：74-78, 2011
  13. 田中　篤、滝川　一
    PSCおよびIgG４関連硬化性胆管炎の疫学．肝胆膵, 62：763-768, 2011
  14. 滝川　一
    特集：膵・胆道の良性～低悪性度病変　原発性硬化性胆管炎（PSC）．臨牀消化器内科, 26：513-518, 2011
  15. 滝川　一
    EBM Update：便秘型過敏性腸症候群の女性に対するケノデオキシコール酸：薬力学的および薬理遺伝子学的検討．bios, 16(II) (9)：10-10, 2011
  16. 滝川　一
    胆道医が知っておくべき“胆汁酸の基礎と臨床”．胆道, 25：189-195, 2011
  17. 滝川　一
    胆汁生成と分泌．小児内科, 43：967-970, 2011
  18. 山本貴嗣、久山　泰
    特集：NSAIDs潰瘍　消化器内科領域．日本臨床, 69(6)：1072-1074, 2011
  19. 山本貴嗣、白井告、磯野朱里、江波戸直久、三科友二、阿部浩一郎、石井太郎、久山泰、松田圭二、渡邉聡明、福島純一
    狭窄型虚血性小腸炎の1例．胃と腸, 46(10)：1544-1550, 2011
  20. 山本貴嗣、久山　泰
    特集：低用量アスピリン時代の消化器内視鏡　NSAIDsによる食道粘膜傷害．消化器内視鏡, 23(7)：1190-1193, 2011
  21. 山本貴嗣、久山　泰
    急性下痢へのクリティカルケア　下痢と便秘―今日的アプローチ―．Medicina, 49(2)：245-248, 2011
  22. 白井　告、磯野朱里、三科友二、江波戸直久、阿部浩一郎、安食　元、山本貴嗣、石井太郎、久山　泰
    内視鏡にて止血し得た小腸出血の1例．Progress of Digestive Endoscopy, 78(2)：116-117, 2011
  23. 佐仲雅樹、瓜田純久、山本貴嗣、久山　泰
    右側臥位が水の胃排出に及ぼす影響―肝機能呼気試験における胃排出能の影響を除けるか？―．安定同位と生体ガス　医学応用, 3(1)：10-12, 2011
  24. Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y, Kohtake H, Furui S
    Isolated dissection of the supramesenteric artery and conservative treatment．J Med Cases, 3(2)：153-154, 2012
  25. Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y
    Choledochoduodenal fistula associated with recurrent peptic ulcer．J Med Cases, 3(4)：243-246, 2012
  26. Yamamoto T, Abe K, Anjiki H, Ishii T, Kuyama Y
    Expanding growth and pharyngeal mass formation in elderly patient with esophageal cancer –unusual manifestation-．J Med cases, 3(3)：211-213, 2012

コメントは停止中です。